US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies

Watchlist

131.240
-0.040-0.03%

Close Mar 4 16:00 ET

131.240
0.0000.00%

Post 17:04 ET

13.95BMarket Cap-182.28P/E (TTM)

Intra-Cellular Therapies Stock Forum

Meta Moo

Jan 17 12:53

Columns Johnson & Johnson Sees Possible Bullish Chart Ahead of Earnings

$Johnson & Johnson (JNJ.US)$ will report Q4 numbers next Wednesday (Jan. 22) at a time when the medical company’s stock has been under the weather, falling back some 14% since early September even as the S&P 500 gained about 7%. What does JNJ's technical and fundamental analysis say could happen from here?
Let's look:
Johnson & Johnson's Fundamental Analysis
The Street is looking for JNJ to report $2.04 in adjusted Q4 earnings per sha...

Kevin Travers

Jan 13 15:07

Columns Wall Street Today: Market Turns Around, Let's See if it Lasts

Overall, the market pulled a fast one on traders on Monday. The S&P 500 started down but built into a climb by the end of the day.
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ climbed 0.16%, the $Dow Jones Industrial Average (.DJI.US)$ was climbing 0.86%, and the $Nasdaq Composite Index (.IXIC.US)$ fell 0.38%.
MACRO
In macroeconomic news this week, watch for Fed speakers, CPI inflation data on Wednesday, and Retail sale data on Thursday.
SECTORS
This week is the s...

Weekly Buzz

Kevin Travers

Jan 13 09:52

Columns Live Stock News: Monday Market Falling, 'Too Big to Fail' Earnings to Start Q1 Report Season

Happy Monday, January 13th. The market began the week falling, but you'll never guess why: here's the Live Stock news.
$Moderna (MRNA.US)$ is falling 21% on Monday, the lowest percentage decliner on the S&P 500 after the firm updated its 2025 guidance, slashing its sales and revenue guidance by $1B, from a range of $2.5-$3.5B it gave in Sept.
$Micron Technology (MU.US)$ was one of the largest percentage ...

Live Stock Financial Podcast. What are you watching on the market?

103418136

Jan 13 08:35

$Intra-Cellular Therapies (ITCI.US)$ am i buy too high at $125?

Movers and Shakers

Jan 13 07:45

Columns Today's Pre-Market Movers and Top Ratings | ANF, LULU, ITCI and More

Morning Movers
Gapping up
$Lululemon Athletica (LULU.US)$ shares climbed 3.9% after the company raised its current-quarter targets, driven by strong holiday-season demand for its apparel.
$Enfusion (ENFN.US)$ shares surged 12% after Clearwater Analytics (NYSE:CWAN), which rose 1.7%, announced a $1.5 billion cash-and-stock acquisition of the investment management platform.
$Intra-Cellular Therapies (ITCI.US)$ shares skyrocketed 35% ...

Teo knows

Jan 13 05:38

$Intra-Cellular Therapies (ITCI.US)$ love this news lets make money

Tonyco

Oct 9, 2024 22:43

Columns Scribblings of a madman!

Ready for some research results?
Summary: XTNT is really undervalued and oversold. Also, ITCI, I guess. Not LLY though, fuck them.

Meltyy

Apr 1, 2024 02:47

Biotech Stock Catalyst Watchlist

🎯 Ph 3 readouts in Q2 2024...
$Intra-Cellular Therapies (ITCI.US)$ Phase 3
$CG Oncology (CGON.US)$ Phase 3
$Hutchmed (China) (HCM.US)$ Phase 3
$Viracta Therapeutics (VIRX.US)$ Phase 3
$GlycoMimetics (GLYC.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3
$FibroGen (FGEN.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$Lyra Therapeutics (LYRA.US)$ Phase 3
$Citius Pharmaceuticals (CTXR.US)$ Phase 3
$Marinus Pharmaceuticals (MRNS.US)$ Phase 3
$BioCardia (BCDA.US)$ Phase 3...

Moomoo AI

Mar 27, 2024 10:03

Intra-Cellular Therapies is nearing breakeven, contingent on maintaining a 57% annual growth rate. Its lack of debt, unusual for a pharma company, reduces investment risk.